Legal Cannabis Use Common Among Cancer Patients

Share this content:
Legal Cannabis Use Common Among Cancer Patients
Legal Cannabis Use Common Among Cancer Patients

MONDAY, Oct. 2, 2017 (HealthDay News) -- In Washington state, where cannabis is legal, cancer patients have high rates of active use, and they report that legalization was an important factor in their decision to use, according to a study published online Sept. 25 in Cancer.

Steven A. Pergam, M.D., M.P.H., from the Fred Hutchinson Cancer Research Center in Seattle and colleagues conducted an anonymous survey of 926 adult cancer patients in Washington to determine the prevalence and methods of use of cannabis. Analysis of random urine samples for tetrahydrocannabinol provided survey validation.

The researchers found that most respondents had a strong interest in learning about cannabis during treatment (6 on a 1-10 scale) and wanted information from cancer providers (74 percent). Previous use was common (66 percent), with 24 percent using cannabis in the last year, 21 percent using cannabis in the last month, and 14 percent reporting weekly use. Cannabis was used for physical (75 percent) and neuropsychiatric symptoms (63 percent). In more than half of respondents, legalization significantly increased the likelihood of use.

"This study of cancer patients in a state with legalized cannabis found high rates of active use across broad subgroups, and legalization was reported to be important in patients' decision to use," conclude the authors. "Cancer patients desire but are not receiving information about cannabis use during their treatment from oncology providers."

Several authors report financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »